Eviq.org.au Website Review

To see all protocols that comply with the WHO Essential Medicine List    A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments. The default diluent for paclitaxel is changing from glucose 5% to sodium chloride 0.9% to reflect clinical practice and longer stability data. Diluents are included on eviQ as defaults only and glucose 5% is still a suitable option. New eviQ Education module. This course presents information about the epidemiology, clinical manifestations and management principles of Following the 1st August 2018 expanded PBS listing for pegfilgrastim to include primary prophylaxis for patients with >20% risk of FN, eviQ is reviewing all impacted protocols. Further information of protocol updates will follow. See eviQ's Program Director Professor Robyn Ward talk about how and why eviQ was developed, its purpose and the governance processes that Earn CPD hours with eviQ education We offer evidence-based cancer on-line learning resources free for all Contribute to the collective of practising medical, nursing and allied health clinicians across Australia who develop and review eviQ Request new content for development Submit requests for protocols or other clinical docu*ents for We acknowledge the traditional custodians of the lands on which we work and live, and pay our respect to Elders past, present and future.